Policy implications of the diffusion and control of medical technology.
Medical technology has become a controversial national policy issue, largely because of rapidly rising national health expenditures and their relation to medical technology. These costs are increasingly viewed in relation to benefits or effectiveness. Attempts to control medical technology, to consider benefits in relation to costs, have largely been regulatory, and have failed to ameliorate cost rises. This failure has stimulated consideration of the reimbursement system as a controlling device. The Medicare program already has developed a rather formal process for making reimbursement decisions based on technology assessments. However, fundamental reform of the reimbursement system seems necessary to counter perverse incentives built into payment. Recent proposals to shift to prospective payment is an example of such a change. However, the basically private nature of the health care system and the limited leverage of the Medicare program limits the power of the federal government to make change.
D003142:Communication; D004059:Diffusion of Innovation; D006291:Health Policy; D006278:Medicare / Q000191:economics; D013673:Technology Assessment, Biomedical; D013675:Technology, High-Cost / Q000639:trends*; D014481:United States